Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses.

Human pathology - 1 Mar 2017

Sakai Yasuhiro, Hong Seung-Mo, An Soyeon, Kim Joo Young, Corbeil Denis, Karbanová Jana, Otani Kyoko, Fujikura Kohei, Song Ki-Byung, Kim Song Cheol, Akita Masayuki, Nanno Yoshihide, Toyama Hirochika, Fukumoto Takumi, Ku Yonson, Hirose Takanori, Itoh Tomoo, Zen Yoh

Abstract excerpt

The present study aimed to elucidate whether the stemness molecule, CD133, is expressed in well-differentiated pancreatic neuroendocrine tumors (PanNETs; World Health Organization grades 1 and 2) and establish its clinical relevance using 2 separate cohorts. In the first series (n = 178) in which tissue microarrays were available, immunohistochemistry revealed that CD133 was expressed in 14 cases (8%). CD133+...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Keratin-19

Share to Neoplasm Grading

Share to Neoplasm Invasiveness

Share to Neoplasm Recurrence, Local

Share to Neuroendocrine Tumors

Share to Tissue Array Analysis

Source

Identifiers

PMID: 27864124
DOI: 10.1016/j.humpath.2016.10.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses.PMID 27864124Read ↗

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-UpSemantic proximity Read ↗

Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors.Semantic proximity Read ↗

mRNA Profiling of a Well-differentiated G1 Pancreatic NET Correlates with Immunohistochemistry ProfileSemantic proximity Read ↗

PKD-1 Signaling Is Required for the Maintenance of CSCs with Epithelial-mesenchymal Plasticity in Pancreatic Neuroendocrine TumorsSemantic proximity Read ↗

Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors GradesSemantic proximity Read ↗

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasisSemantic proximity Read ↗

Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.Semantic proximity Read ↗

A Biomarker-Based Characterisation of EMT and Neuroendocrine Differentiation States in Pancreatic and Small Cell Hypercalcemic Ovarian Tumor Cells and Their Modulation by Transforming Growth Factor-β and Bone Morphogenetic Protein-7Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.